McConaghy Acquires Cure Marine Brand and Intellectual Property

McConaghy recently acquired the brand and intellectual property of Cure Marine, the renowned Australian builder of high-performance sailing catamarans.

What began as a potential production partnership has evolved into a full integration of the brand into the McConaghy portfolio, according to the company. Under this new structure, McConaghy will take over the manufacturing of the Cure range, transitioning production to McConaghy’s facilities to leverage their composite engineering and autoclave technologies.

Cure Marine has now concluded operations, according to the company, with production of the Cure range transitioning to McConaghy. To ensure continuity, McConaghy has appointed Ed Penn as Sales Manager for the Cure series. Ed, a pivotal figure in Cure’s initial success, joins the McConaghy team to lead the brand’s global commercial efforts.

“We saw a unique opportunity to bring a successful Australian design into the McConaghy fold,” said Mark Evans, Group Managing Director of McConaghy, in a news release. “By combining Cure’s performance-driven IP with McConaghy’s global production scale and technical expertise, we are ensuring a bright and sustainable future for these exceptional catamarans. “We are also delighted to welcome Ed Penn to the McConaghy team as Sales Manager for the Cure series, bringing over 30 years of industry experience and ensuring continuity and expertise for our clients.”

McConaghy is already undertaking a design evolution of the Cure 55GT and Cure 48GT models, according to the company, with further details on these refined iterations expected to be unveiled later this month.